Skip to main content

Table 3 Demographic characteristics of AE reports submitted for H1-antihistamines of interest in FAERS

From: Data mining in FAERS: association of newer-generation H1-antihistamines with nervous system disorders

N(%)

Certirizine

Levocetirizine

Loratadine

Desloratadine

Fexofenadine

Variables

Gender

     

Female

6692(49·4%)

2396(39·2%)

6654(53·3%)

355(58·3%)

4556(41·2%)

Male

3392(25·0%)

869(14·2%)

3777(30·3%)

225(36·9%)

2188(19·8%)

Not Specified

3476(25·6%)

2846(46·6%)

2048(16·4%)

29(4·8%)

4312(39·0%)

Age

     

0–18

1144(8·4%)

225(3·7%)

1562(12·5%)

103(16·9%)

346(3·1%)

19–65

3226(23·8%)

777(12·7%)

2438(19·5%)

253(41·5%)

1934(17·5%)

> 65

1616(11·9%)

530(8·7%)

2453(19·7%)

111(18·2%)

1809(16·4%)

Unknow

7574(55·9%)

4579(74·9%)

6026(48·3%)

142(23·3%)

6967(63·0%)

Reporters

     

Consumers

11,074(81·7%)

5619(91·9%)

11,433(91·6%)

181(29·7%)

10,486(94·8%)

Physician

803(5·9%)

218(3·6%)

139(1·1%)

178(29·2%)

212(1·9%)

Health professionals

538(4·0%)

39(0·6%)

131(1·0%)

81(13·3%)

101(0·9%)

Pharmacists

275(2·0%)

176(2·9%)

51(0·4%)

45(7·4%)

125(1·1%)

Lawyers

2(0·0%)

0(0·0%)

2(0·0%)

0(0·0%)

1(0·0%)

Others

868(6·4%)

59(1·0%)

723(5·8%)

124(20·4%)

131(1·2%)

Total

13,560

6111

12,479

609

11,056